Managing Pediatric Atopic Dermatitis
A DermTalks Podcast – Atopic Dermatitis in Special Populations. This podcast series is dedicated to exploring the management of atopic dermatitis in specific patient groups.
Speaker : Dr. Hannah de Leye, UZ Brussel, Belgium

Atopic dermatitis (AD) is a prevalent chronic inflammatory skin condition that affects more than 20% of children in industrialized countries1. Children who develop AD have a higher risk of developing other allergic diseases such as allergic asthma, allergic rhinitis, and food allergies2. This is why, in the management of pediatric AD, the atopic march and possible food allergies needs to be carefully considered.
In this DermTalks podcast episode, Dr. Hannah de Leye, physician, and dermatologist in training at UZ Brussel, currently working at UZ Leuven in Belgium, shares her insights on the atopic march, food allergies, including IgE testing and restrictive diets, as well as early interventions that may help restore skin barrier function and prevent the progression of atopic diseases.
"As AD often precedes the development of other atopic diseases, early intervention in young pediatric patients could possibly restore epithelial barrier integrity and function, potentially preventing the inflammatory response and the development of the atopic march2,12.
Consulting with a pediatrician and food allergy specialist before starting a restrictive diet in any child with AD is essential. Specific IgE testing is often used in clinical practice as a work-up in children with AD, but these tests often have no value in diagnosing real food allergy and can lead to unnecessary elimination of foods. It is important to ask about other symptoms and consider the child's overall health and growth7-10."
Dr. Hannah de Leye
Dermatologist in training, UZ Brussel, Belgium
Key highlights
The prevalence of atopic comorbidities in AD at any age is higher than in the general population, with AD and these comorbidities exhibiting numerous shared genetic risk variants5. More severe AD is associated with an increased likelihood of atopic comorbidities, including asthma2,6.
Article of interest:
The Atopic March
The concept of the "atopic march" describes the sequential progression of AD, food allergy (FA), allergic asthma (AA), allergic rhinitis (AR), and allergic conjunctivitis (AC)2. According to this theory, the disruption of the epidermal barrier in AD triggers sensitization to epicutaneous allergens and inflammation, leading to an immune response that subsequently extends to other epithelial surfaces, including the gastrointestinal tract, resulting in food allergies, the upper respiratory tract, leading to allergic rhinitis, and the lower respiratory tract, contributing to allergic asthma2,3.
Food Allergy in Young Children with AD
Infants with AD have a six-fold higher risk of developing IgE-mediated food allergy compared with infants without AD7. Symptoms often include gastrointestinal issues such as vomiting, diarrhea, constipation, cramps, and lung manifestations.
Management of Food Allergy: Do’s and Don’t
Dermatologists and general practitioners frequently search for links between skin exacerbations and food, leading to prescribed skin prick tests and specific IgE tests in blood. However, sensitization to many food elements is often found in children with AD, resulting in prescribed diets7.
1. Restrictive diets
Recent studies have shown the importance of including common food allergens in the diets of infants9. Dietary elimination for the treatment of AD may slightly improve the condition but does not account for the potential harm of a diet in young children. Some studies suggest that diet restriction at a young age can increase the risk of developing food allergies, as exposure to different types of food is necessary to maintain immune tolerance. Elimination of certain foods may improve AD in some patients with true food-triggered AD but can also lead to the future development of IgE-mediated FA, including anaphylaxis. Furthermore, children who eliminate two or more foods from their diet are more likely to reach lower height percentiles and be vitamin D deficient. Therefore, a general diet based on specific IgE tests should be approached with caution7,8.
2. IgE testing
Specific IgE testing may be useful in predicting food allergy in patients with moderate-severe AD, but the decision points may be much higher than those that apply to a less atopic population8. Furthermore, IgE testing alone is not diagnostic for food allergies, so adding a diagnostic oral food challenge could help guide the clinical significance of specific IgE sensitization10.
The Benefits of Early intervention in Children
An intact skin epithelium is crucial for preventing further allergic manifestations. There is some evidence, although not established, that early application of skin emollients can reduce the risk of AD development or delay its onset11. This also raises the question of whether treatment with biologics that restore epithelial barrier integrity may prevent the inflammatory response and the development of the atopic march12. Since treatment with biologics is now approved at a very young age, future research will be able to answer this question12.
Conclusion
As AD often precedes the development of other atopic diseases, early intervention in young pediatric patients could possibly restore epithelial barrier integrity and function, potentially preventing the inflammatory response and the development of the atopic march2,12. Consulting with a pediatrician and food allergy specialist before starting a restrictive diet in any child with AD is essential. Specific IgE testing is often used in clinical practice as a work-up in children with AD, but these tests often have no value in diagnosing real food allergy and can lead to unnecessary elimination of foods. It is important to ask about other symptoms and consider the child's overall health and growth7-10.
References
-
Roduit C et al. Phenotypes of Atopic Dermatitis Depending on the Timing of Onset and Progression in Childhood. JAMA Pediatr. 2017 Jul 1;171(7):655-662.
-
Han H et al. The atopic march: current insights into skin barrier dysfunction and epithelial cell-derived cytokines. 2017 Jul;278(1):116-130.
-
Zhu TH et al. Epithelial barrier dysfunctions in atopic dermatitis: a skin-gut-lung model linking microbiome alteration and immune dysregulation. Br J Dermatol. 2018 Sep;179(3):570-581
-
Biagini et al. Longitudinal atopic dermatitis endotypes: An atopic march paradigm that includes Black children. Atopic dermatitis and inflammatory skin disease. Volume 149, Issue 5p1702-1710.e4May 2022.
-
Ferreira MA et al. Shared genetic origin of asthma, hay fever and eczema elucidates allergic disease biology. Nat Genet. 2017 Dec;49(12):1752-1757.
-
Thyssen JP et al. Comorbidities of atopic dermatitis-what does the evidence say? J Allergy Clin Immunol. 2023 May;151(5):1155-1162.
-
Oykhman, Paul et al. “Dietary Elimination for the Treatment of Atopic Dermatitis: A Systematic Review and Meta-Analysis.” The journal of allergy and clinical immunology. In practice vol. 10,10 (2022): 2657-2666.e8.
-
Kubala SA et al. Challenge of food allergy testing and avoidance in children with atopic dermatitis. BMJ Case Rep. 2021 Jun 4;14(6):e243141.
-
Perkin et al. Efficacy of the Enquiring About Tolerance (EAT) study among infants at high risk of developing food allergy. J Allergy Clin Immunol. 2019 Dec;144(6):1606–1614.e2.
-
Christie Lynn et al; Food Allergies in Children Affect Nutrient Intake and Growth CHRISTIE, Journal of the American Dietetic Association, Volume 102, Issue 11, 1648 – 1651.
-
Chaoimh et al. Early initiation of short-term emollient use for the prevention of atopic dermatitis in high-risk infants-The STOP-AD randomised controlled trial. Allergy. 2023 Apr;78(4):984-994.
-
Ghezzi M et al. Barrier Impairment and Type 2 Inflammation in Allergic Diseases: The Pediatric Perspective. Children (Basel). 2021 Dec 9;8(12):1165.